Overexpression of CXCR4 can promote the proliferation and invasion of ovarian cancer cells, while the inhibitor AMD3100 and shRNA silencing CXCR4 can inhibit epithelial-mesenchymal transition, thereby inhibiting tumor proliferation, metastasis, and cell activation [34]. Here, CXCR4 is linked to ovarian cancer.